Next Article in Journal
Translating the Manufacture of Immunotherapeutic PLGA Nanoparticles from Lab to Industrial Scale: Process Transfer and In Vitro Testing
Next Article in Special Issue
Formulation and Evaluation of the In Vitro Performance of Topical Dermatological Products Containing Diclofenac Sodium
Previous Article in Journal
Evaluation of the Formulation Parameter-Dependent Redispersibility of API Nanoparticles from Fluid Bed Granules
Previous Article in Special Issue
AKVANO®: A Novel Lipid Formulation System for Topical Drug Delivery—In Vitro Studies
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(8), 1689; https://doi.org/10.3390/pharmaceutics14081689
Action Date Notes Link
article pdf uploaded. 13 August 2022 12:39 CEST Version of Record https://www.mdpi.com/1999-4923/14/8/1689/pdf-vor
article supplementary file uploaded. 13 August 2022 12:39 CEST - https://www.mdpi.com/1999-4923/14/8/1689#supplementary
article xml file uploaded 16 August 2022 05:04 CEST Original file -
article xml uploaded. 16 August 2022 05:04 CEST Update -
article pdf uploaded. 16 August 2022 05:04 CEST Updated version of record https://www.mdpi.com/1999-4923/14/8/1689/pdf-vor
article html file updated 16 August 2022 05:06 CEST Original file -
article html file updated 16 August 2022 10:10 CEST Update -
article xml file uploaded 23 August 2022 19:55 CEST Update -
article xml uploaded. 23 August 2022 19:55 CEST Update https://www.mdpi.com/1999-4923/14/8/1689/xml
article pdf uploaded. 23 August 2022 19:55 CEST Updated version of record https://www.mdpi.com/1999-4923/14/8/1689/pdf
article html file updated 23 August 2022 19:57 CEST Update https://www.mdpi.com/1999-4923/14/8/1689/html
Back to TopTop